Alyeska Investment Group’s Qualigen Therapeutics QLGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Hold |
0
| – | – | – | 561 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 537 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 431 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 443 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 438 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 471 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 399 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 409 |
|
|
2018
Q3 | – | Sell |
-23
| Closed | -$753K | – | 458 |
|
|
2018
Q2 | $753K | Sell |
23
-12
| -34% | -$393K | 0.01% | 378 |
|
|
2018
Q1 | $1.2M | Sell |
35
-1
| -3% | -$34.4K | 0.01% | 351 |
|
|
2017
Q4 | $1.47M | Hold |
36
| – | – | 0.01% | 331 |
|
|
2017
Q3 | $1.56M | Buy |
36
+34
| +1,700% | +$1.48M | 0.01% | 362 |
|
|
2017
Q2 | $161K | Sell |
2
-1
| -33% | -$80.5K | ﹤0.01% | 417 |
|
|
2017
Q1 | $500K | Sell |
3
-2
| -40% | -$333K | ﹤0.01% | 436 |
|
|
2016
Q4 | $1.77M | Buy |
+5
| New | +$1.77M | 0.01% | 385 |
|